Check out our most recent publication in Nature Sustainability - Water-based coupling of amino acids for sustainable solid-phase peptide synthesis
MacroGel was set up as a focused outlet for the promotion and sales of macroporous hydrogels developed at Spheritech Ltd. These novel, innovative porous matrices have a broad a range of applications including solid phase peptide synthesis, solid phase oligonucleotide synthesis, enzyme immobilisation, antibody immobilisation, oral peptide drug delivery, subcutaneous drug delivery, 3D cell culture, immobilised metal affinity chromatography (IMAC), metal extraction and disinfection to name a few.
Don Wellings is the founder, Managing Director and Chief Scientific Officer at SpheriTech Ltd.
Don is an internationally recognised authority on peptide synthesis, polymer design, and chromatography with over 40 years’ experience of working in major blue-chip organisations having held senior scientific posts in ICI, Zeneca, Avecia, and Polymer Laboratories. Prior to founding Spheritech he founded Chromatide where he worked as Chief Scientific Officer for 3 years and was credited as the sole inventor of all of the company’s intellectual property.
With a track record of innovation, he is the main inventor on over 20 patents and the sole inventor on all patents filed by SpheriTech to date.
Josh Greenwood is the lead research scientist at SpheriTech Ltd, where he plays a central role in driving R&D, process scale‑up, and manufacturing for the products supplied through MacroGel.
With over seven years at SpheriTech Ltd, he has worked across peptide chemistry and materials science, focusing on improving solid‑ and liquid‑phase peptide synthesis and developing new polymeric materials. His current projects include creating a fully aqueous amide‑coupling strategy and engineering porous and non‑porous SpheriTide supports (such as the hydrophilic SpheriTide Aq and Aq‑M) for water‑based SPPS.